Sangam Health Care Products H1 profit nearly doubles to Rs 65.88 lakh

Sangam Health Care Products Limited reported first-half profit after tax of Rs 65.88 lakh for the half year ended 30 September 2026, up from Rs 33.62 lakh a year earlier, after total income rose to Rs 6.16 crore and total expenses declined to Rs 5.24 crore.

What were Sangam Health Care Products' first-half earnings?

Sangam Health Care Products reported profit after tax of Rs 65.88 lakh for the half year ended 30 September 2026, compared with Rs 33.62 lakh in the corresponding half year ended 30 September 2025. The Rs 32.26 lakh increase equates to about 96% based on the reported figures. Profit before tax rose to Rs 92.19 lakh from Rs 38.90 lakh, while total income increased by Rs 30.75 lakh from Rs 5.86 crore to Rs 6.16 crore.

The company reported basic and diluted earnings per share of Rs 0.44 for the six-month period, compared with Rs 0.23 in the prior-year half. The filing says the earnings-per-share figure is not annualised. Paid-up equity share capital was Rs 14.86 crore at 30 September 2026, unchanged from Rs 14.86 crore at 30 September 2025 and 31 March 2026.

The board reviewed and approved the unaudited results on 13 November 2026 after audit committee review. The statutory auditor's limited review report, dated 13 November 2026, said nothing had come to its attention suggesting that the statement did not make the disclosures required under Regulation 33 of the Securities and Exchange Board of India listing regulations.

How did Sangam Health Care Products' September quarter compare?

Sangam Health Care Products reported Rs 35.25 lakh of profit after tax for the quarter ended 30 September 2026, compared with Rs 23.36 lakh in the quarter ended 30 September 2025. Quarterly total income rose to Rs 3.13 crore from Rs 3.04 crore, an increase of Rs 9.84 lakh. The increase in quarterly profit after tax was Rs 11.89 lakh.

Profit before tax in the September 2026 quarter was Rs 49.28 lakh, against Rs 28.41 lakh a year earlier. The September-quarter profit after tax also exceeded the Rs 30.63 lakh reported in the quarter ended 30 June 2026. Total income was Rs 3.03 crore in the June 2026 quarter, below the Rs 3.13 crore reported for the September quarter.

The two reported quarterly profit-before-tax figures, Rs 42.91 lakh for June 2026 and Rs 49.28 lakh for September 2026, add to Rs 92.19 lakh for the first half. For the year ended 31 March 2026, the company reported total income of Rs 11.25 crore and profit after tax of Rs 5.33 lakh. That annual figure is a reported historical comparator, not a projection for the year ending March 2027.

What changed in Sangam Health Care Products' costs and tax?

Sangam Health Care Products reported total expenses of Rs 5.24 crore for the half year ended 30 September 2026, down from Rs 5.47 crore in the corresponding prior-year half. Expenses fell by Rs 22.55 lakh while total income rose by Rs 30.75 lakh. These two movements coincided with profit before tax increasing by Rs 53.29 lakh to Rs 92.19 lakh.

Material consumption and purchases of stock-in-trade were Rs 3.22 crore in the latest half, compared with Rs 1.44 crore a year earlier. Finance cost was Rs 90.61 lakh, up from Rs 81.65 lakh, while other expenditure was Rs 2.89 lakh against Rs 2.51 lakh. The filing's aggregate expense figure therefore reflects movements across expense lines rather than a uniform decline in every reported cost category.

The results statement lists current tax of Rs 23.97 lakh and deferred tax of Rs 2.35 lakh for the half year ended 30 September 2026. Those figures together are Rs 26.32 lakh, compared with the Rs 26.31 lakh difference between reported profit before tax of Rs 92.19 lakh and profit after tax of Rs 65.88 lakh, with the Rs 0.01 lakh difference attributable to rounding in the displayed results. For the corresponding half, profit before tax was Rs 38.90 lakh and profit after tax was Rs 33.62 lakh.

What do Sangam Health Care Products' balance sheet and cash flow show?

Sangam Health Care Products reported total assets of Rs 11.94 crore at 30 September 2026, compared with Rs 11.22 crore at 31 March 2026. Current assets increased to Rs 6.16 crore from Rs 5.34 crore. Trade receivables rose to Rs 4.04 crore from Rs 3.52 crore, while inventories declined to Rs 88.28 lakh from Rs 1.01 crore.

Total liabilities were Rs 23.35 crore at 30 September 2026, compared with Rs 23.56 crore at 31 March 2026. Total equity remained negative at Rs 19.19 crore, compared with negative Rs 19.85 crore at 31 March 2026. The Rs 65.87 lakh improvement in total equity broadly matches the Rs 65.88 lakh first-half profit after tax, subject to rounding in the balance-sheet presentation.

The cash-flow statement reported Rs 21.81 lakh of net cash from operating activities for the period ended 30 September 2026. Repayment of borrowings was Rs 21.25 lakh and interest paid was Rs 4, producing net cash used in financing activities of Rs 21.30 lakh. Cash and cash equivalents consequently rose by Rs 51,000 from Rs 15.17 lakh at the beginning of the year to Rs 15.68 lakh at period end.

Conclusion

The first-half results show higher reported profit alongside a moderate rise in income and lower aggregate expenses. Profit after tax rose by Rs 32.26 lakh to Rs 65.88 lakh, while profit before tax increased by Rs 53.29 lakh to Rs 92.19 lakh. The September 2026 quarter accounted for Rs 35.25 lakh of first-half profit after tax, compared with Rs 30.63 lakh in the June quarter.

The filing does not disclose a management earnings target, operating plan or date for the next financial results. Subsequent company disclosures will be relevant for any change in the Rs 4.04 crore trade-receivables balance, Rs 15.68 lakh cash balance and negative Rs 19.19 crore total equity reported at 30 September 2026.